April 27, 2020 /

Italfarmaco Provides Givinostat Update (April 22, 2020)

Parent Project Muscular Dystrophy by: Parent Project Muscular Dystrophy

Italfarmaco Provides Givinostat Update (April 22, 2020)

On April 22, 2020, Italfarmaco joined Parent Project Muscular Dystrophy for a webinar to update the community about Italfarmaco’s development of Givinostat and the recent results of the futility analysis of the enrolling Phase 3 confirmatory study in Duchenne muscular dystrophy.

Research & Clinical Trial Webinars,
Webinars

Join Our Mailing List

This field is for validation purposes and should be left unchanged.
BBB Accredited Charity logoCharity Navigator Four Star Charity logoNational Health Council Standards of Excellence Certification Program logo